Alprostadil
6 NDCs across 2 manufacturers|0 Generic,6 Brand
Alprostadil is used to treat aortic arch syndromes, aortic coarctation, patent ductus arteriosus, pulmonary hypertension, hypoplastic left heart syndrome and vasculogenic impotence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 20, 1998.
Alprostadil is available as 6 NDCs from 2 manufacturers (0 generic, 6 brand), with NADAC prices from $82.49 to $237.37 per EA — the most expensive product costs about 2.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
2
competing in market
Price Spread
$82.49 – $237.37
per EA
7d Activity
avg +0.6% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pharmacia & Upjohn Company LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Prostaglandin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ALPROSTADIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EDEX 20 MCG CARTRIDGE 2-PK KIT | $237.3720 per EA | +1.20% |
EDEX 10 MCG CARTRIDGE 2-PK KIT | $182.9167 per EA | — |
CAVERJECT 40 MCG VIAL | $125.1112 per EA | — |
CAVERJECT IMPULSE 20 MCG KIT | $106.2377 per EA | -0.06% |
CAVERJECT 20 MCG VIAL | $95.7151 per EA | — |
CAVERJECT IMPULSE 10 MCG KIT | $82.4905 per EA | — |
Frequently Asked Questions
What is Alprostadil used to treat?
Alprostadil is used to treat aortic arch syndromes, aortic coarctation, patent ductus arteriosus, pulmonary hypertension, hypoplastic left heart syndrome and vasculogenic impotence, per the National Library of Medicine's MED-RT classification.
When did Alprostadil become available as a generic?
FDA approved the first generic Alprostadil (ANDA) on Jan 20, 1998.
How many Alprostadil products are on the market?
The Alprostadil drug market contains 6 NDCs from 2 manufacturers — 0 generic and 6 brand products.
What is the price range for Alprostadil?
NADAC reference prices for Alprostadil range from $82.4905 to $237.3720 per EA — the most expensive product costs about 2.9× the cheapest.
Which manufacturers make Alprostadil?
2 manufacturers list Alprostadil in NADAC. Ranked by number of NDCs, the largest are Pharmacia & Upjohn Company LLC (4), Endo USA Inc. (2).
How has the price of Alprostadil changed recently?
Over the past 7 days, 2 Alprostadil NDCs rose and 2 fell, with a market-wide average change of +0.6%.